• Alcon is down 6% in Tuesday trading after releasing updated 2024 guidance that included lowering the net sales range and narrowing the EPS range.
• The eye care focused company now sees net sales of $9.8B-$9.9B, down from $9.9B-$10.1B prior. The revenue consensus figure is $9.94B.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。